Literature DB >> 29549086

Clinical and functional impact of recurrent S1PR1 mutations in mantle cell lymphoma.

Agata M Wasik1, Chenglin Wu2, Larry Mansouri3,4, Richard Rosenquist3,4, Qiang Pan-Hammarström2, Birgitta Sander1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29549086      PMCID： PMC5873236          DOI： 10.1182/bloodadvances.2017014860

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  26 in total

Review 1.  Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.

Authors:  Jason G Cyster; Susan R Schwab
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

2.  Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma.

Authors:  Lina Nygren; Stefanie Baumgartner Wennerholm; Monika Klimkowska; Birger Christensson; Eva Kimby; Birgitta Sander
Journal:  Blood       Date:  2012-03-19       Impact factor: 22.113

3.  Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways.

Authors:  Daniel J Medina; Lauri Goodell; John Glod; Céline Gélinas; Arnold B Rabson; Roger K Strair
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

Review 4.  The complex landscape of genetic alterations in mantle cell lymphoma.

Authors:  Cristina Royo; Itziar Salaverria; Elena M Hartmann; Andreas Rosenwald; Elías Campo; Sílvia Beà
Journal:  Semin Cancer Biol       Date:  2011-09-18       Impact factor: 15.707

5.  The hematopoietic oncoprotein FOXP1 promotes tumor cell survival in diffuse large B-cell lymphoma by repressing S1PR2 signaling.

Authors:  Michael Flori; Corina A Schmid; Eric T Sumrall; Alexandar Tzankov; Charity W Law; Mark D Robinson; Anne Müller
Journal:  Blood       Date:  2016-01-04       Impact factor: 22.113

6.  Expression of sphingosine-1-phosphate receptor 1 in mantle cell lymphoma.

Authors:  Hirotake Nishimura; Takashi Akiyama; Yasumasa Monobe; Kiminori Matsubara; Yasuyuki Igarashi; Masafumi Abe; Takashi Sugihara; Yoshito Sadahira
Journal:  Mod Pathol       Date:  2010-01-15       Impact factor: 7.842

7.  Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia.

Authors:  Laura Patrussi; Nagaja Capitani; Veronica Martini; Marco Pizzi; Valentina Trimarco; Federica Frezzato; Filippo Marino; Gianpietro Semenzato; Livio Trentin; Cosima T Baldari
Journal:  Cancer Res       Date:  2015-08-17       Impact factor: 12.701

8.  Sphingosine-1-phosphate receptor 1 as a prognostic biomarker and therapeutic target for patients with primary testicular diffuse large B-cell lymphoma.

Authors:  Risa Koresawa; Kazuto Yamazaki; Daigo Oka; Hideyo Fujiwara; Hirotake Nishimura; Takashi Akiyama; Shuji Hamasaki; Hideho Wada; Takashi Sugihara; Yoshito Sadahira
Journal:  Br J Haematol       Date:  2016-04-08       Impact factor: 6.998

9.  Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas.

Authors:  Jin Ho Paik; Soo Jeong Nam; Tae Min Kim; Dae Seog Heo; Chul-Woo Kim; Yoon Kyung Jeon
Journal:  BMC Cancer       Date:  2014-12-03       Impact factor: 4.430

10.  Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.

Authors:  Noel F C C de Miranda; Konstantinos Georgiou; Longyun Chen; Chenglin Wu; Zhibo Gao; Apostolos Zaravinos; Susana Lisboa; Gunilla Enblad; Manuel R Teixeira; Yixin Zeng; Roujun Peng; Qiang Pan-Hammarström
Journal:  Blood       Date:  2014-08-29       Impact factor: 22.113
View more
  5 in total

Review 1.  S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.

Authors:  Narges Rostami; Afshin Nikkhoo; Amir Ajjoolabady; Gholamreza Azizi; Mohammad Hojjat-Farsangi; Ghasem Ghalamfarsa; Bahman Yousefi; Mehdi Yousefi; Farhad Jadidi-Niaragh
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

Review 2.  Sphingolipids and Lymphomas: A Double-Edged Sword.

Authors:  Alfredo Pherez-Farah; Rosa Del Carmen López-Sánchez; Luis Mario Villela-Martínez; Rocío Ortiz-López; Brady E Beltrán; José Ascención Hernández-Hernández
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

3.  Evaluation of S1PR1, pSTAT3, S1PR2, FOXP1 Expression in Aggressive, Mature B Cell Lymphomas.

Authors:  Mustafa Al-Kawaaz; Teresa Sanchez; Michael J Kluk
Journal:  J Hematop       Date:  2019-04-27       Impact factor: 0.196

Review 4.  Migration and Adhesion of B-Lymphocytes to Specific Microenvironments in Mantle Cell Lymphoma: Interplay between Signaling Pathways and the Epigenetic Landscape.

Authors:  Laia Sadeghi; Anthony P Wright
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

5.  Differential B-Cell Receptor Signaling Requirement for Adhesion of Mantle Cell Lymphoma Cells to Stromal Cells.

Authors:  Laia Sadeghi; Gustav Arvidsson; Magali Merrien; Agata M Wasik; André Görgens; C I Edvard Smith; Birgitta Sander; Anthony P Wright
Journal:  Cancers (Basel)       Date:  2020-05-02       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.